Fraunhofer Institute for Cell Therapy and Immunology IZI

Leipzig Immune ONcology (LION) Conference

Virtual conference | November 9–10, 2021 | Register now and submit your abstract for our digital poster session until June 7, 2021. For the latest conference updates sign up for our newsletter.

more info

We transfer biomedical research into the clinic.

The Fraunhofer Institute for Cell Therapy and Immunology IZI investigates and develops solutions to specific problems at the interfaces of medicine, life sciences and engineering. One of the institute‘s main tasks is to conduct contract research for companies, hospitals, diagnostic laboratories and research institutes operating in the field of biotechnology, pharma­ceuticals and medical engineering.

The Fraunhofer IZI develops, optimizes and validates methods, materials and products for the business units Cell and Gene Therapy, Drugs and Diagnostics. Its areas of competence lie in cell biology, immunology, drug biochemistry, bioanalytics and bioproduction as well as process development and automation. In these areas, research specifically focusses on the indications oncology, immunological diseases as well as infectious diseases and neurodegenerative diseases.

The institute works in close cooperation with hospital institutions and performs quality tests besides carrying out the GMP-compliant manufacture of clinical test samples. Furthermore, it helps partners obtain manufacturing licenses and permits.


Latest press releases


Periodontitis: Researchers search for a new active substance

Targeted, efficient and with few side effects: A new method for combating periodontitis could render the use of broad-spectrum antibiotics superfluous. It was developed and tested for the first time by a team from Martin Luther University Halle-Wittenberg (MLU), the Fraunhofer Institute for Cell Therapy and Immunology IZI and Periotrap Pharmaceuticals GmbH, a Fraunhofer IZI spin-off. The aim is to neutralise only bacteria that cause periodontitis while sparing harmless bacteria. The study appeared in the "Journal of Biological Chemistry".
Read more


SaxoCell – “living drug” Made in Saxony

Saxony-based consortium comes out on top in the BMBF Clusters4Future initiative. In a digital press conference held by the German Federal Ministry of Education and Research (BMBF) on February 3, 2021, the SaxoCell research consortium was announced as one of the clusters selected for funding. The consortium comprises experts from the TU Dresden, Leipzig University, Chemnitz Hospital and the Fraunhofer Institute for Cell Therapy and Immunology. Over the next three years, the project partners will collaborate with partners from academia and industry to provide novel cell and gene therapies for previously incurable diseases.
Read more


Optimization of novel immune cell therapies

Fraunhofer Institute for Cell Therapy and Immunology IZI and Klinikum Chemnitz gGmbH (Chemnitz hospital) expand cooperation
Read more


Rapid diagnostic device for trachoma eye infection delivers first promising result

A molecular biological, chip-based rapid test for the diagnosis of the eye infection trachoma developed at the Fraunhofer Institute for Cell Therapy and Immunology IZI has proven promising in first studies. The results of the study carried out together with the London School of Hygiene & Tropical Medicine and the Kilimanjaro Christian Medical Centre, Tanzania, have now been published in the journal "Parasites & Vectors". The development of the DjinniChip was supported by the ClearTrachoma project of the non-profit organization Task Force for Global Health in a program of the Coalition for Operational Research on Neglected Tropical Diseases (COR-NTD).
Read more

Press / media


As an institution of application-oriented research, the Fraunhofer Institute for Cell Therapy and Immunology IZI attaches great importance to informing customers and the public.



The Fraunhofer IZI offers its partners and guests space for communication.

Utilize our modern and representative premises for your event. The generously proportioned and modern space offered at the Institute provides space for, e. g., workshops, symposia, conferences and lectures.



United against Corona


West Nile Virus on the rise in Europe

The European Centre for Disease Prevention and Control has been recording the rising spread of the virus in Europe and its neighboring countries for many years now.


Annual report 2019

The annual report gives you an insight into the structure of the Fraunhofer IZI, our services, important events and publications, offers, as well as selected project examples.

Research projects funded by the EU

Research projects at Fraunhofer IZI that are supported by the Land of Saxony / Saxony-Anhalt / Mecklenburg-Western Pomerania using funds provided by the European Regional Development Fund (ERDF).


Business units and core competencies

The Fraunhofer IZI offers R&D services for pharmaceutical, biotechnological and medical technology companies as well as for partners from research institutions, hospitals and diagnostic laboratories.

Jobs / career

We keep you informed on current job offers at the Fraunhofer IZI. Find out about the possibilities the Fraunhofer-Gesellschaft could offer you as an employer.


We gladly provide our clients and partners as well as the interested public with information on our research activities.



Fraunhofer IZI


Perlickstraße 1
04103 Leipzig

Phone +49 341 35536-1000
Fax +49 341 35536-8-1000


Social Media